Prexton Therapeutics Competitors and Similar CompaniesClear all

Prexton Therapeutics's competitors and similar companies include MorphoSys, Pyxant Labs and Opko Health.

	Prexton Therapeutics Prexton Therapeutics applies a new scientific approach that fully integrates molecular, behavioural and chemistry technologies to address Parkinson’s disease and other brain disorders.	MorphoSys MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.	Pyxant Labs Pyxant Labs is a company operating as a bioanalytical laboratory.	Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
Founding Date	Founding Date 2012	Founding Date 1992	Founding Date 2000	Founding Date 2007
Type	Type Subsidiary	Type Subsidiary	Type Private	Type Public
Tags	Tags Healthcare biotech medical diagnostics pharma	Tags Healthcare biotech medical diagnostics pharma	Tags Healthcare biotech medical diagnostics pharma	Tags Healthcare biotech medical diagnostics pharma
Locations	Locations Oss, NL HQ Plan Les Ouates, CH	Locations Planegg, DE HQ Boston, US	Locations Colorado Springs, US HQ Millcreek, US	Locations Miami, US HQ Woburn, US
Employees	Employees 1	Employees 464	Employees 1221% decrease	Employees 6,0967% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €238.3m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) $606.9m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods €34.6m (FY, 2023)	Cost of goods N/A	Cost of goods $400.9m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit €205.5m (FY, 2023)	Gross profit N/A	Gross profit $205.9m (FY, 2025)
Net income	Net income N/A	Net income (€189.7m) (FY, 2023)	Net income N/A	Net income ($225.7m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 41.1m	Total funding raised $ 126m	Total funding raised $ 530k	Total funding raised $ 31m